Renzo Mazzarotto

2.3k total citations
63 papers, 1.5k citations indexed

About

Renzo Mazzarotto is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Renzo Mazzarotto has authored 63 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 26 papers in Oncology and 18 papers in Surgery. Recurrent topics in Renzo Mazzarotto's work include Thyroid Cancer Diagnosis and Treatment (16 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Renal cell carcinoma treatment (8 papers). Renzo Mazzarotto is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (16 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Renal cell carcinoma treatment (8 papers). Renzo Mazzarotto collaborates with scholars based in Italy, United States and Germany. Renzo Mazzarotto's co-authors include Dario Casara, Domenico Rubello, Antonio Toniato, Maria Rosa Pelizzo, Stefano Fanti, Andrea Piotto, Paolo Bernante, C Pagetta, Paolo Castellucci and Francesco Ceci and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Renzo Mazzarotto

60 papers receiving 1.5k citations

Peers

Renzo Mazzarotto
Donald R. Neumann United States
Homer Macapinlac United States
M Walther United States
Renzo Mazzarotto
Citations per year, relative to Renzo Mazzarotto Renzo Mazzarotto (= 1×) peers Gaia Grassetto

Countries citing papers authored by Renzo Mazzarotto

Since Specialization
Citations

This map shows the geographic impact of Renzo Mazzarotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renzo Mazzarotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renzo Mazzarotto more than expected).

Fields of papers citing papers by Renzo Mazzarotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renzo Mazzarotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renzo Mazzarotto. The network helps show where Renzo Mazzarotto may publish in the future.

Co-authorship network of co-authors of Renzo Mazzarotto

This figure shows the co-authorship network connecting the top 25 collaborators of Renzo Mazzarotto. A scholar is included among the top collaborators of Renzo Mazzarotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renzo Mazzarotto. Renzo Mazzarotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bianco, Paola Del, Mario Romano, Gabriella Rossi, et al.. (2021). Long-Term Outcomes Using Electron IOERT APBI for Early Stage Breast Cancer: The Verona University Hospital Experience. Clinical Breast Cancer. 22(2). e167–e172. 2 indexed citations
2.
Bellometti, S, Filippo Alongi, L. Corti, et al.. (2020). Radiotherapy activities and technological equipment in Veneto, Italy: a report from the Rete Radioterapica Veneta. La radiologia medica. 126(4). 623–629. 3 indexed citations
3.
Rastrelli, Marco, Paolo Del Fiore, Alessandra Buja, et al.. (2020). A Therapeutic and Diagnostic Multidisciplinary Pathway for Merkel Cell Carcinoma Patients. Frontiers in Oncology. 10. 529–529. 5 indexed citations
4.
Mazzarotto, Renzo, Gabriella Rossi, Riccardo De Robertis, et al.. (2020). Dosimetric Feasibility Study of Dose Escalated Stereotactic Body Radiation Therapy (SBRT) in Locally Advanced Pancreatic Cancer (LAPC) Patients: It Is Time to Raise the Bar. Frontiers in Oncology. 10. 600940–600940. 12 indexed citations
5.
Arcelli, A., A. Guido, Milly Buwenge, et al.. (2019). Higher Biologically Effective Dose Predicts Survival in SBRT of Pancreatic Cancer: A Multicentric Analysis (PAULA-1). Anticancer Research. 40(1). 465–472. 33 indexed citations
7.
Confalonieri, Marco, et al.. (2016). Out-patient high-dose-rate endobronchial brachytherapy for palliation of lung cancer: an observational study. Monaldi Archives for Chest Disease. 67(3). 128–34. 3 indexed citations
8.
Farina, E., Giovanni Tallini, Andrea Repaci, et al.. (2015). Unusual Thyroid Carcinoma Metastases: a Case Series and Literature Review. Endocrine Pathology. 27(1). 55–64. 50 indexed citations
9.
Pettinato, Cinzia, Emiliano Spezi, Cristina Nanni, et al.. (2014). Pretherapeutic Dosimetry in Patients Affected by Metastatic Thyroid Cancer Using 124I PET/CT Sequential Scans for 131I Treatment Planning. Clinical Nuclear Medicine. 39(8). e367–e374. 18 indexed citations
10.
Ceci, Francesco, Ken Herrmann, Paolo Castellucci, et al.. (2014). Impact of 11C-choline PET/CT on clinical decision making in recurrent prostate cancer: results from a retrospective two-centre trial. European Journal of Nuclear Medicine and Molecular Imaging. 41(12). 2222–2231. 80 indexed citations
11.
Bartenstein, Peter, C.L. Maini, Renzo Mazzarotto, et al.. (2013). High-Risk Patients with Differentiated Thyroid Cancer T4 Primary Tumors Achieve Remnant Ablation Equally Well Using rhTSH or Thyroid Hormone Withdrawal. Thyroid. 24(3). 480–487. 23 indexed citations
12.
Ceci, Francesco, Paolo Castellucci, Tiziano Graziani, et al.. (2013). 11C-Choline PET/CT detects the site of relapse in the majority of prostate cancer patients showing biochemical recurrence after EBRT. European Journal of Nuclear Medicine and Molecular Imaging. 41(5). 878–886. 48 indexed citations
13.
Vianello, Federica, Renzo Mazzarotto, Caterina Mian, et al.. (2011). Clinical Outcome of Low-risk Differentiated Thyroid Cancer Patients after Radioiodine Remnant Ablation and Recombinant Human Thyroid-stimulating Hormone Preparation. Clinical Oncology. 24(3). 162–168. 6 indexed citations
14.
Toniato, Antonio, Isabella Merante Boschin, Dario Casara, et al.. (2008). Papillary Thyroid Carcinoma: Factors Influencing Recurrence and Survival. Annals of Surgical Oncology. 15(5). 1518–1522. 125 indexed citations
15.
Betalli, Pietro, Federica De Corti, D Minucci, et al.. (2008). Successful topical treatment with mitomycin‐C in a female with post‐brachytherapy vaginal stricture. Pediatric Blood & Cancer. 51(4). 550–552. 6 indexed citations
16.
Mian, Caterina, Susi Barollo, Gianmaria Pennelli, et al.. (2007). Molecular characteristics in papillary thyroid cancers (PTCs) with no 131I uptake. Clinical Endocrinology. 68(1). 108–116. 106 indexed citations
17.
Mazzarotto, Renzo, Caterina Boso, Giovanni Scarzello, et al.. (2002). Radiotherapy Alone in the Treatment of Clinical Stage I-IIA, Nonbulky, Hodgkin’s Disease. American Journal of Clinical Oncology. 25(2). 149–152.
18.
Mazzarotto, Renzo, et al.. (2000). The role of external beam radiotherapy in the management of differentiated thyroid cancer. Biomedicine & Pharmacotherapy. 54(6). 345–349. 18 indexed citations
19.
Busnardo, B, Otello Daniele, Renzo Mazzarotto, et al.. (2000). A multimodality therapeutic approach in anaplastic thyroid carcinoma: Study on 39 patients. Journal of Endocrinological Investigation. 23(11). 755–761. 51 indexed citations
20.
Salvagno, Luigi, Mariella Sorarů, Guido Sotti, et al.. (1995). Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. Annals of Oncology. 6(2). 173–179. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026